INHIBITION OF THE MYELOID MASTER REGULATOR PU.1 AS A THERAPEUTIC STRATEGY IN ACUTE MYELOID LEUKEMIA

被引：0

作者：

Antony-Debre, I. ^{[1
,2
]}

Leite, J. ^{[1
]}

Paul, A. ^{[3
]}

Mitchell, K. ^{[1
]}

Kim, H. M. ^{[3
]}

Huang, K. ^{[3
]}

Kumar, A. ^{[3
]}

Farahat, A. A. ^{[3
]}

Bartholdy, B. ^{[1
]}

Narayanagari, S. -R. ^{[1
]}

Carvajal, L. A. ^{[1
]}

Chen, J. ^{[1
]}

Ambesi-Impiombato, A. ^{[4
]}

Ferrando, A. A. ^{[4
]}

Mantzaris, I. ^{[1
]}

Gavathiotis, E. ^{[1
]}

Verma, A. ^{[1
]}

Will, B. ^{[1
]}

Boykin, D. W. ^{[3
]}

Wilson, W. D. ^{[3
]}

Poon, G. M. K. ^{[3
]}

Steidl, U. ^{[1
]}

机构：

[1] Albert Einstein Coll Med, Albert Einstein Canc Ctr, New York, NY USA

[2] Gustave Roussy, Inserm U1170, Villejuif, France

[3] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA

[4] Columbia Univ, Inst Canc Genet, New York, NY USA

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

S135

引用

页码：18 / 18

页数：1

共 50 条

[41] HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target
Lulu Liu
Jingjing Zhang
Xianning Zhang
Panpan Cheng
Lei Liu
Qian Huang
Haihui Liu
Saisai Ren
Peng Wei
Cuiling Wang
Cuiyun Dou
Lulu Chen
Xin Liu
Hao Zhang
Mingtai Chen
Journal of Molecular Medicine, 2021, 99 : 107 - 118
[42] Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia
Aue, Georg
Du, Yang
Cleveland, Susan M.
Smith, Stephen B.
Dave, Utpal P.
Liu, Delong
Weniger, Marc A.
Metais, Jean Yves
Jenkins, Nancy A.
Copeland, Neal G.
Dunbar, Cynthia E.
BLOOD, 2011, 118 (17) : 4674 - 4681
[43] PU.1 expression is restored upon treatment of chronic myeloid leukemia patients
Albajar, Marta
Gutierrez, Pilar
Richard, Carlos
Rosa-Garrido, Manuel
Teresa Gomez-Casares, M.
Steegmann, Juan L.
Leon, Javier
Dolores Delgado, M.
CANCER LETTERS, 2008, 270 (02) : 328 - 336
[44] Targeted Inhibition of STAT/TET1 Axis As a Potent Therapeutic Strategy for Acute Myeloid Leukemia
Jiang, Xi
Hu, Chao
Ferchen, Kyle
Nie, Ji
Cui, Xiaolong
Chen, Chih-Hong
Cheng, Liting
Zuo, Zhixiang
Seibel, William
He, Chunjiang
Tang, Yixuan
Skibbe, Jennifer R.
Wunderlich, Mark
Reinhold, William C.
Dong, Lei
Shen, Chao
Arnovitz, Stephen
Ulrich, Bryan
Lu, Jiuwei
Weng, Hengyou
Su, Rui
Huang, Huilin
Wang, Yungui
Li, Chenying
Qin, Xi
Mulloy, James C.
Zheng, Yi
Diao, Jiajie
Jin, Jie
Li, Chong
Liu, Paul P.
He, Chuan
Chen, Yuan
Chen, Jianjun
BLOOD, 2017, 130
[45] ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression
Mueller, BU
Pabst, T
Fos, J
Petkovic, V
Fey, MF
Asou, N
Buergi, U
Tenen, DG
BLOOD, 2006, 107 (08) : 3330 - 3338
[46] PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1
Pianigiani, Giulia
Betti, Camilla
Bigerna, Barbara
Rossi, Riccardo
Brunetti, Lorenzo
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (01) : 184 - 187
[47] ANALYSIS OF PU.1 INTERACTIONS IN DIFFERENTIATING MYELOID CELLS
SRIKANTH, S
RADO, TA
BLOOD, 1994, 84 (10) : A133 - A133
[48] Dendritic Cells as a Therapeutic Strategy in Acute Myeloid Leukemia: Vaccines
Palomares, Francisca
Pina, Alejandra
Dakhaoui, Hala
Leiva-Castro, Camila
Munera-Rodriguez, Ana M.
Cejudo-Guillen, Marta
Granados, Beatriz
Alba, Gonzalo
Santa-Maria, Consuelo
Sobrino, Francisco
Lopez-Enriquez, Soledad
VACCINES, 2024, 12 (02)
[49] Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia
Tabe, Yoko
Tafuri, Agostino
Sekihara, Kazumasa
Yang, Haeun
Konopleva, Marina
EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (07) : 705 - 714
[50] Combined inhibition of cKIT and Lysine-Specific Demethylase 1 as a therapeutic strategy in acute myeloid leukemia.
Smith, Brittany M.
Coleman, Daniel J.
Maloney, Lauren
Coblentz, Cody
Schonrock, Zachary
Estabrook, Joseph
Lusardi, Theresa
Druker, Brian J.
Maxson, Julia E.
Braun, Theodore P.
CANCER RESEARCH, 2021, 81 (13)

← 1 2 3 4 5 →